We deduced from the above results that the HDDA NBs could induce the ICD of B16F10 tumor cells and produce HMVs for immunostimulation, which would stimulate DCs, improve the intratumoral T cell infiltration, and further potentiate PD-1 blockade therapy. This evidence concerns the gene PDCD1 and neoplasm.